Atlas Trials

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Clinical trial NCT05252754 · RECRUITING

Trial details

NCT number
NCT05252754
Sponsor
Johns Hopkins University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Post-ERCP Acute Pancreatitis
Start date
2023-01-18
Primary completion
2026-12-01
Enrollment
4874

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.